2m 2m 2m 2m 2m 2m 2m
Procyon (PCYN)
OTC
$0.28+$0.02 (+7.69%)
Price as of Jul 29, 2026- $2.3MMarket Cap
- 47.37%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Procyon (PCYN)
$0.28+$0.02 (+7.69%)
Annual
Quarterly
06/30/2024 | 06/30/2023 | 06/30/2022 | 06/30/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.0M +6.35% | 4.7M -3.22% | 4.8M +2.60% | 4.7M N/A | |
Cost of Revenue | 1.1M -2.16% | 1.1M -17.66% | 1.4M +1.93% | 1.3M N/A | |
Gross Profit | 3.9M +9.02% | 3.6M +2.40% | 3.5M +2.87% | 3.4M N/A | |
Sales and Marketing Expense | 2.0M +12.78% | 1.8M +5.63% | 1.7M +28.60% | 1.3M N/A | |
Research and Development Expense | -30,100 -1.63% | -30,600 +2.00% | -30,000 -2.91% | -30,900 N/A | |
Depreciation and Amortization Expense | 81,701 +54.69% | 52,817 +38.20% | 38,217 -11.80% | 43,331 N/A | |
Total Operating Expenses | 1.1M -2.16% | 1.1M -17.66% | 1.4M +1.93% | 1.3M N/A | |
Operating Profit | -231,705 +137.94% | -97,381 -58.95% | -237,215 -204.65% | 226,674 N/A | |
Interest Income | 24,641 +108.54% | 11,816 N/A | 0 -100.00% | 1,232 N/A | |
Interest Expense | 0 N/A | 0 N/A | 0 +100.00% | -2,172 N/A | |
Interest Income and Expense and Net | 24,641 +108.54% | 11,816 N/A | 0 +100.00% | -940 N/A | |
Total Nonoperating Income and Expense | 60,423 +88.78% | 32,007 +1,674.22% | 1,804 -99.64% | 507,119 N/A | |
Income before Taxes | -171,282 +162.00% | -65,374 -72.23% | -235,411 -132.08% | 733,793 N/A | |
Income Taxes | 169,858 +1,222.73% | -15,129 -40.95% | -25,621 -164.96% | 39,444 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -341,140 +578.95% | -50,245 -76.05% | -209,790 -130.21% | 694,349 N/A | |
Net Income from Continuing Operations Applicable to Common | -312,962 +367.42% | -66,955 -70.44% | -226,500 -133.42% | 677,639 N/A | |
Basic EPS and Net Income | -0.04 +300.00% | -0.01 -66.67% | -0.03 -137.50% | 0.08 N/A | |
Diluted EPS and Net Income | -0.04 +300.00% | -0.01 -66.67% | -0.03 -137.50% | 0.08 N/A | |
Basic Weighted Average Shares | 8.1M +0.41% | 8.1M 0.00% | 8.1M 0.00% | 8.1M N/A | |
Diluted Weighted Average Shares | 8.1M +0.41% | 8.1M 0.00% | 8.1M -2.79% | 8.3M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 326,143 -27.73% | 451,306 -40.65% | 760,396 -38.00% | 1.2M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 326,143 -27.73% | 451,306 -40.65% | 760,396 -38.00% | 1.2M N/A | |
Total Current Assets | 2.4M +5.73% | 2.2M -13.44% | 2.6M -9.98% | 2.9M N/A | |
Accumulated Depreciation | 296,683 -8.95% | 325,860 +19.34% | 273,043 +6.75% | 255,788 N/A | |
Property and Plant and Equipment and Net | 262,020 -6.76% | 281,023 +82.84% | 153,702 +40.66% | 109,275 N/A | |
Total Long-Term Assets | 262,020 -6.76% | 281,023 +82.84% | 153,702 +40.66% | 109,275 N/A | |
Total Assets | 3.2M -10.08% | 3.6M -6.28% | 3.8M -10.89% | 4.3M N/A | |
Income Taxes Payable | 8,677 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 769,234 +22.86% | 626,120 -2.66% | 643,231 -12.56% | 735,587 N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | 201,000 0.00% | 201,000 N/A | |
Total Long-Term Liabilities | 147,888 -53.77% | 319,882 -34.89% | 491,312 -24.86% | 653,860 N/A | |
Total Liabilities | 917,122 -3.05% | 946,002 -16.62% | 1.1M -18.35% | 1.4M N/A | |
Retained Earnings | -2.3M +17.15% | -2.0M +2.59% | -1.9M +12.13% | -1.7M N/A | |
Total Stockholders Equity | 2.3M -12.62% | 2.6M -1.88% | 2.7M -7.29% | 2.9M N/A | |
Total Shares Outstanding | 8.1M +0.41% | 8.1M 0.00% | 8.1M 0.00% | 8.1M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -61,251 -142.11% | 145,466 +163.40% | -229,459 -182.10% | 279,500 N/A | |
Capital Expenditures | 63,912 -64.52% | 180,138 +117.97% | 82,644 +26.82% | 65,166 N/A | |
Cash from Investing Activities | -63,912 -85.94% | -454,556 +450.02% | -82,644 -117.21% | 480,137 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 0 N/A | 0 +100.00% | -154,023 -22.58% | -198,949 N/A | |
Financials Ratio | |||||
Gross Margin | 78.07% +2.50% | 76.16% +5.81% | 71.98% +0.26% | 71.80% N/A | |
Operating Margin | -4.65% +123.73% | -2.08% -57.58% | -4.90% -202.00% | 4.80% N/A | |
Return on Assets | -10.08% +638.95% | -1.36% -73.76% | -5.20% -126.54% | 19.59% N/A | |
Return on Equity | -13.91% +631.64% | -1.90% -74.87% | -7.57% -127.47% | 27.55% N/A | |
Revenue Growth | 6.35% +297.51% | -3.22% -223.68% | 2.60% -70.76% | 8.90% N/A | |
Current Ratio | 3.08 -13.94% | 3.57 -11.08% | 4.02 +2.95% | 3.90 N/A | |
Cash Ratio | 0.42 -41.18% | 0.72 -39.03% | 1.18 -29.10% | 1.67 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.08 +7.88% | 0.07 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.05 +12.31% | 0.05 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow